Maravai LifeSciences Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Thanks for joining us today on day 3 of our Healthcare Conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector at Morgan Stanley. Delighted to have Maravai join us today. And representing the company, we have Carl Hull, CEO; and Kevin Herde, CFO. Welcome to you both, gents.
Before we get into the Q&A, just some important disclosures. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales rep.
Questions & Answers
So with that, Carl, I mean, just to kick things off, maybe for people on the call who are not as familiar with the Maravai story, can you give us a high-level overview of the company? And what do you view as Maravai's greatest accomplishments since the IPO last year?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |